| Santos Emmanuel Santos Fontanez, | |
|
593 Eddy St, Providence, RI 02903-4923 | |
| (787) 981-7040 | |
| Not Available |
| Full Name | Santos Emmanuel Santos Fontanez |
|---|---|
| Gender | Male |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 593 Eddy St, Providence, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811545015 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | LP05438 (Rhode Island) | Secondary |
| 390200000X | Student In An Organized Health Care Education/training Program | (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Santos Emmanuel Santos Fontanez, Hc 2 Box 48152, Vega Baja, PR 00693-9678 Ph: () - | Santos Emmanuel Santos Fontanez, 593 Eddy St, Providence, RI 02903-4923 Ph: (787) 981-7040 |
News Archive
Professor Bill Keevil, Head of the Microbiology Group and Director of the Environmental Healthcare Unit at the University of Southampton, has presented research into the mechanism by which copper exerts its antimicrobial effect on antibiotic-resistant organisms at the World Health Organization's first International Conference on Prevention and Infection Control.
Pacira Pharmaceuticals, Inc. today announced consolidated financial results for the quarter ended March 31, 2012 and reviewed recent accomplishments, including the commercial launch in the United States of EXPAREL (bupivacaine liposome injectable suspension) for postsurgical pain and the successful completion of an equity financing.
The justices could announce as early as Tuesday whether they will review provisions in the Affordable Care Act requiring employers of a certain size to offer insurance coverage for birth control and other reproductive health services without a co-pay. The owners of more than three dozen for-profit companies have argued that complying with that provision would violate their religious beliefs.
Texas Children's Hospital and SynCardia Systems, Inc. announced today that Texas Children's has become the world's first pediatric hospital to complete the first phase of certification to implant the SynCardia temporary Total Artificial Heart. The hospital intends to use the Total Artificial Heart as a bridge to transplant for their patients who received a heart transplant as children and now require mechanical support as a bridge to their second transplant.
› Verified 8 days ago